CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sjögren's syndrome G Nocturne, R Seror, O Fogel, R Belkhir, S Boudaoud, A Saraux, ... Arthritis & rheumatology 67 (12), 3226-3233, 2015 | 102 | 2015 |
Epigenetic changes in chronic inflammatory diseases O Fogel, C Richard-Miceli, J Tost Advances in protein chemistry and structural biology 106, 139-189, 2017 | 65 | 2017 |
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis D Wendling, S Hecquet, O Fogel, JG Letarouilly, F Verhoeven, T Pham, ... Joint Bone Spine 89 (3), 105344, 2022 | 56 | 2022 |
Role of the IL-12/IL-35 balance in patients with Sjögren syndrome O Fogel, E Rivière, R Seror, G Nocturne, S Boudaoud, B Ly, ... Journal of Allergy and Clinical Immunology 142 (1), 258-268. e5, 2018 | 48 | 2018 |
Early‐onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome J Poline, O Fogel, C Pajot, C Miceli‐Richard, M Rybojad, C Galeotti, ... Journal of the European Academy of Dermatology and Venereology 34 (2), 340-348, 2020 | 30 | 2020 |
Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis O Fogel, A Bugge Tinggaard, M Fagny, N Sigrist, E Roche, L Leclere, ... Arthritis Research & Therapy 21, 1-14, 2019 | 28 | 2019 |
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients J Avouac, C Miceli-Richard, A Combier, A Steelandt, O Fogel, ... Rheumatology 61 (SI2), SI163-SI168, 2022 | 26 | 2022 |
Development of enthesopathies and joint structural damage in a murine model of X-linked hypophosphatemia CA Faraji-Bellée, A Cauliez, B Salmon, O Fogel, V Zhukouskaya, A Benoit, ... Frontiers in Cell and Developmental Biology 8, 854, 2020 | 16 | 2020 |
Epilepsy mortality in Wales during COVID-19 H Daniels, AS Lacey, D Mikadze, A Akbari, B Fonferko-Shadrach, ... Seizure 94, 39-42, 2022 | 13 | 2022 |
Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic J Avouac, A Molto, C Frantz, S Wanono, E Descamps, O Fogel, A Combier, ... The Journal of Rheumatology 49 (11), 1269-1275, 2022 | 11 | 2022 |
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases J Avouac, O Fogel, S Hecquet, C Daien, I Elalamy, F Picard, C Prati, ... Joint Bone Spine 90 (5), 105592, 2023 | 6 | 2023 |
Actualisation 2022 des recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite … D Wendling, S Hecquet, O Fogel, JG Letarouilly, F Verhoeven, T Pham, ... Revue du Rhumatisme 89 (3), 210-222, 2022 | 4 | 2022 |
Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases C Gros, AA Mariaggi, JF Meritet, E André, M Boisson, A Combier, ... Joint Bone Spine 89 (3), 105312, 2022 | 3 | 2022 |
Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection J Avouac, R Ghossan, O Al Tabaa, A Combier, A Steelandt, M Thomas, ... Rheumatology 61 (SI2), SI191-SI193, 2022 | 2 | 2022 |
Étude prospective de séroprévalence du Sars-Cov-2 chez 249 patients suivis pour un rhumatisme inflammatoire chronique O Fogel, AA Mariaggi, JF Méritet, E André, M Boisson, A Combier, ... Revue du Rhumatisme 87, A292-A293, 2020 | 2 | 2020 |
Évaluation systématique de la réponse humorale contre le SARS-CoV-2 dans une cohorte française de 283 patients atteints d’un rhumatisme inflammatoire chronique C Gros, AA Mariaggi, JF Meritet, E André, M Boisson, A Combier, ... Revue du rhumatisme 89 (4), 405-411, 2022 | 1 | 2022 |
Internat de rhumatologie en France: évaluation de l’ancien système et inconnues de la R3C O Fogel, S Bitoun Revue du Rhumatisme 87 (3), 157-161, 2020 | 1 | 2020 |
OP0062 Assessment of biotherapies' efficacy in blau syndrome: data from an international retrospective cohort of 23 cases O Fogel, A Cantagrel, K Ikeda, P Sève, E Hachulla, R Cimaz, P Sfriso, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 77-77, 2017 | 1 | 2017 |
Genetic Variant and High Levels of CCL11 in Serum Are Associated with the Occurrence of Lymphoma and Disease Activity in Primary Sjogren's Syndrome Patients (pSS). G Nocturne, O Fogel, J Nititham, KE Taylor, P Dieude, JJ Dubost, ... ARTHRITIS & RHEUMATOLOGY 66, S226-S227, 2014 | 1 | 2014 |
CXCL13 Serum Levels Is Associated with Lymphoma, High B Cells Markers and Diseases activity in Primary Sjogren's Syndrome Patients. G Nocturne, O Fogel, P Dieude, JJ Dubost, AL Fauchais, V Goeb, ... ARTHRITIS & RHEUMATOLOGY 66, S227-S227, 2014 | 1 | 2014 |